Literature DB >> 21925111

Receptor binding enables botulinum neurotoxin B to sense low pH for translocation channel assembly.

Shihu Sun1, Swetha Suresh, Huisheng Liu, William H Tepp, Eric A Johnson, J Michael Edwardson, Edwin R Chapman.   

Abstract

Botulinum neurotoxins (BoNTs, serotypes A-G), elaborated by Clostridium botulinum, can induce lethal paralysis and are classified as Category A bioterrorism agents. However, how BoNTs translocate from endosomes into the cytosol of neurons to gain access to their intracellular targets remains enigmatic. We discovered that binding to the ganglioside GT1b, a toxin coreceptor, enables BoNT/B to sense low pH, undergo a significant change in secondary structure, and transform into a hydrophobic oligomeric membrane protein. Imaging of the toxin on lipid bilayers using atomic force microscopy revealed donut-shaped channel-like structures that resemble other protein translocation assemblies. Toosendanin, a drug with therapeutic effects against botulism, inhibited GT1b-dependent BoNT/B oligomerization and in parallel truncated BoNT/B single-channel conductance, suggesting that oligomerization plays a role in the translocation reaction. Thus, BoNT/B functions as a coincidence detector for receptor and low pH to ensure spatial and temporal accuracy for toxin conversion into a translocation channel.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21925111      PMCID: PMC3243646          DOI: 10.1016/j.chom.2011.06.012

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  50 in total

1.  Architecture of the protein-conducting channel associated with the translating 80S ribosome.

Authors:  R Beckmann; C M Spahn; N Eswar; J Helmers; P A Penczek; A Sali; J Frank; G Blobel
Journal:  Cell       Date:  2001-11-02       Impact factor: 41.582

2.  Toosendanin interferes with pore formation of botulinum toxin type A in PC12 cell membrane.

Authors:  Mu-feng Li; Yu-liang Shi
Journal:  Acta Pharmacol Sin       Date:  2006-01       Impact factor: 6.150

Review 3.  Botulinum toxin as a biological weapon: medical and public health management.

Authors:  S S Arnon; R Schechter; T V Inglesby; D A Henderson; J G Bartlett; M S Ascher; E Eitzen; A D Fine; J Hauer; M Layton; S Lillibridge; M T Osterholm; T O'Toole; G Parker; T M Perl; P K Russell; D L Swerdlow; K Tonat
Journal:  JAMA       Date:  2001-02-28       Impact factor: 56.272

4.  Membrane-embedded synaptotagmin penetrates cis or trans target membranes and clusters via a novel mechanism.

Authors:  J Bai; C A Earles; J L Lewis; E R Chapman
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

5.  Placental alkaline phosphatase is efficiently targeted to rafts in supported lipid bilayers.

Authors:  David E Saslowsky; Jared Lawrence; Xiaoyan Ren; Deborah A Brown; Robert M Henderson; J Michael Edwardson
Journal:  J Biol Chem       Date:  2002-05-14       Impact factor: 5.157

6.  pH-induced conformational changes in Clostridium difficile toxin B.

Authors:  M Qa'Dan; L M Spyres; J D Ballard
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

7.  Structural architecture of an outer membrane channel as determined by electron crystallography.

Authors:  B K Jap; P J Walian; K Gehring
Journal:  Nature       Date:  1991-03-14       Impact factor: 49.962

8.  Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins.

Authors:  L L Simpson; J A Coffield; N Bakry
Journal:  J Pharmacol Exp Ther       Date:  1994-04       Impact factor: 4.030

Review 9.  Neurotoxins affecting neuroexocytosis.

Authors:  G Schiavo; M Matteoli; C Montecucco
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

10.  Structural changes after transmitter release at the frog neuromuscular junction.

Authors:  J E Heuser; T S Reese
Journal:  J Cell Biol       Date:  1981-03       Impact factor: 10.539

View more
  34 in total

1.  Gangliosides interact with synaptotagmin to form the high-affinity receptor complex for botulinum neurotoxin B.

Authors:  Alessandra Flores; Jorge Ramirez-Franco; Richard Desplantes; Kévin Debreux; Géraldine Ferracci; Florian Wernert; Marie-Pierre Blanchard; Yves Maulet; Fahamoe Youssouf; Marion Sangiardi; Cécile Iborra; Michel Robert Popoff; Michael Seagar; Jacques Fantini; Christian Lévêque; Oussama El Far
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-20       Impact factor: 11.205

Review 2.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

3.  Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction.

Authors:  Cesare Colasante; Ornella Rossetto; Laura Morbiato; Marco Pirazzini; Jordi Molgó; Cesare Montecucco
Journal:  Mol Neurobiol       Date:  2013-03-08       Impact factor: 5.590

4.  Interneuronal Transfer and Distal Action of Tetanus Toxin and Botulinum Neurotoxins A and D in Central Neurons.

Authors:  Ewa Bomba-Warczak; Jason D Vevea; Joel M Brittain; Annette Figueroa-Bernier; William H Tepp; Eric A Johnson; Felix L Yeh; Edwin R Chapman
Journal:  Cell Rep       Date:  2016-08-04       Impact factor: 9.423

5.  Tetanus neurotoxin utilizes two sequential membrane interactions for channel formation.

Authors:  Joshua R Burns; Michael R Baldwin
Journal:  J Biol Chem       Date:  2014-06-27       Impact factor: 5.157

Review 6.  Botulinum neurotoxins: genetic, structural and mechanistic insights.

Authors:  Ornella Rossetto; Marco Pirazzini; Cesare Montecucco
Journal:  Nat Rev Microbiol       Date:  2014-06-30       Impact factor: 60.633

Review 7.  Recent developments in cell-based assays and stem cell technologies for botulinum neurotoxin research and drug discovery.

Authors:  Erkan Kiris; Krishna P Kota; James C Burnett; Veronica Soloveva; Christopher D Kane; Sina Bavari
Journal:  Expert Rev Mol Diagn       Date:  2014-01-23       Impact factor: 5.225

8.  The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.

Authors:  B Vijayalakshmi Ayyar; K Roger Aoki; M Zouhair Atassi
Journal:  Infect Immun       Date:  2015-01-26       Impact factor: 3.441

9.  Exocytotic fusion pores are composed of both lipids and proteins.

Authors:  Huan Bao; Marcel Goldschen-Ohm; Pia Jeggle; Baron Chanda; J Michael Edwardson; Edwin R Chapman
Journal:  Nat Struct Mol Biol       Date:  2015-12-14       Impact factor: 15.369

10.  Identification of novel host-targeted compounds that protect from anthrax lethal toxin-induced cell death.

Authors:  Louise H Slater; Erik C Hett; Kevin Mark; Nicole M Chumbler; Deepa Patel; D Borden Lacy; R John Collier; Deborah T Hung
Journal:  ACS Chem Biol       Date:  2013-02-04       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.